Member Info for LordSnooty

Yes, you're right, new XBIO shares are trading on OTCQB and have been since last Friday. The problem is liquidity, since most of us UK holders do not yet have the facilities to either buy or sell.

as I said earlier, it's 17p not 17c, and in any case it just relates to the last closing price on AIM, and is irrelevant now. Wait and see what the price is after 2.30pm UK time, when the US market opens.

should read "...from before our move to the US." of course.

is now showing my new number of shares but with a value per share of 17.277 pence (NOT cents). I'm not sure how they arrive at this exact figure but it's the "latest available closing price", from before our move to the UK. This will adjust as and when we become tradeable in the US.

That's plain weird, where do they get those figures from? If you had 500k old shares you should have 500k divided by 175 times 56 = 160k shares now. As for the 17.22c, where on Earth do they get that figure?

That's in line with what Barclays told me on the phone a week ago. The good news is I spoke to my present broker, iWeb, last week, and they confirmed that they are able to trade XBIO, but only on the sell side. That suits me because I really only have granny's glass beads left in the kitty. In addition, iWeb's commission is as standard - £5 a trade, though plus 1 1/2% on the currency conversion - that compares very favourably with some other UK brokers. I don't know whether the same would apply to newly-opened accounts, but it might be worth a word with them.

I think your last post gets to the core of the problem this company has had for a long time. For at least two years AIM has known about the US listing and that has left us marooned at ridiculous prices. We have all become accustomed to seeing the SP going nowhere and our MCAP in the £20-30m range. Meanwhile biopharma in the US rocketed 70% last year and another 20% so far this year. As Mr M pointed out in his podcasts, there are similar companies to ours but with only a SINGLE drug candidate in early stage trials that are valued at $300-500m in the US. We have multiple candidates, some in late stage trials, and a very much lower risk model. I have no better idea than anyone else where the market will eventually value us, but to me, with news to support in the coming weeks, $2.50 per share and a resulting MCAP of $365m does not seem so implausible. We'll see from Tuesday onwards whether this level holds. I'm not betting on it but neither am I pessimistic.

Closed Monday for President's Day. Open Tuesday 2.30pm UK time.

Prices are not live but 15 mins delayed. It's http://uk.advfn.com. You'll need to register but basic level (contended) is free. Then on your monitor screen search for XBIO and add.

I can't say without knowing the details but clearly there's some misunderstanding that you need to clear up with your broker.

As regards trading your new shares, you need first to check whether your present broker can handle XBIO. If not then you need to start looking around for one that can. If you look back at previous posts on this thread, you will get some advice on which brokers can handle OTCQB market in the US, where we now reside. In particular, look at yesterday's posts from Taximan, which give advice from Xenetic themselves on this matter.

It's very simple: if you held 102,625 shares previously, you now have 102,625 ÷ 175 x 56 = 32,840 new shares. At $2.50 the value is therefore $82,100.

$2.50/$3.00

on the bid. Now $2.25/$3.00 bid/ask.

Share certificate is number 1. Naturally.

Henceforth one wishes to be known as The Peer Formerly Known as Snooty, or TPFKS.

Go to bed, it's past your bedtime and that nice teddy I gave you for Valentine's Day is waiting.

Please keep the thread informed as to how things progress with Stocktrade. I may yet have no better alternative, not that I'm in any hurry either. NASDAQ here we come.

Yes, I too opened a Stocktrade account but the charges seem very steep, so I'm still looking for a better alternative.

thank you for your most gracious and, may I say, apposite reply. I shall put my factotum onto these people to see what they can offer. On another matter entirely, I expect that driving a taxi is a most lucrative profession, is it not?